of DEGs was performed using Gene Ontology (GO) resources, and the cell signaling
pathway analysis of DEGs
Savelieva, Olga,
Karunas, Alexandra,
Prokopenko, Inga,
Balkhiyarova, Zhanna,
Gilyazova, Irina,
Khidiyatova, Irina,
Khusnutdinova, Elza (2025) SNPs of drug
pathway genes involved in the metabolism of glucocorticosteroids (GCS), and beta-2
/macrophages, and their significant role in controlling immune signaling
pathways. Highlighting recent studies in human and animal
Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) and genomics have enabled the identification of specific molecular
pathways and targets, paving the way
of the disease is associated with an impact on genes and signaling
pathways regulating cell proliferation
of mean field theory for intermolecular couplings in photoaligned surfaces, opening up new
pathwaysTimasheva, Yanina,
Kochetova, Olga,
Balkhiyarova, Zhanna,
Korytina, Gulnaz,
Prokopenko, Inga,
Nouwen, Arie (2025) variants across these
pathways in 279 MetS patients and 397 healthy individuals. Using logistic regression
Larionova, Irina,
Iamshchikov, Pavel,
Kazakova, Anna,
Rakina, Militsa,
Menyalo, Maxim,
Enikeeva, Kadriia,
Rafikova, Guzel,
Sharifyanova, Yuliya,
Pavlov, Valentin,
Villert, Alisa,
Kolomiets, Larisa,
Kzhyshkowska, Julia (2025) that chemotherapy inhibited interferon-dependent signaling
pathways, but activated some TGFb-related genes. Our